Trelegy 100 Ellipta 14 doses (テリルジー100エリプタ14吸入用) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

trelegy 100 ellipta 14 doses (テリルジー100エリプタ14吸入用)

glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation

Trelegy 100 Ellipta 30 doses (テリルジー100エリプタ30吸入用) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

trelegy 100 ellipta 30 doses (テリルジー100エリプタ30吸入用)

glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation

Trelegy 200 Ellipta 14 doses (テリルジー200エリプタ14吸入用) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

trelegy 200 ellipta 14 doses (テリルジー200エリプタ14吸入用)

glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation

Trelegy 200 Ellipta 30 doses (テリルジー200エリプタ30吸入用) Japan - English - すりの適正使用協議会 RAD-AR Council, Japan

trelegy 200 ellipta 30 doses (テリルジー200エリプタ30吸入用)

glaxosmithkline k.k. - fluticasone furoate; umeclidinium bromide; vilanterol trifenatate - inhalation

ANORO ELLIPTA INHALATION POWDER 62.5 MCG25 MCG Singapore - English - HSA (Health Sciences Authority)

anoro ellipta inhalation powder 62.5 mcg25 mcg

glaxosmithkline pte ltd - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol - powder, metered - (umec strip) umeclidinium bromide (micronised) 74.2 mcg/dose eqv umeclidinium 62.5 mcg/dose; (vi strip) vilanterol trifenatate (micronised) 40 mcg/dose eqv vilanterol 25 mcg/dose

Incruse Ellipta (previously Incruse) European Union - English - EMA (European Medicines Agency)

incruse ellipta (previously incruse)

glaxosmithkline (ireland) limited - umeclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).,

Rolufta Ellipta (previously Rolufta) European Union - English - EMA (European Medicines Agency)

rolufta ellipta (previously rolufta)

glaxosmithkline trading services limited - umeclidinium bromide - pulmonary disease, chronic obstructive - drugs for obstructive airway diseases, - rolufta is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).,

Incruse Ellipta New Zealand - English - Medsafe (Medicines Safety Authority)

incruse ellipta

glaxosmithkline nz limited - umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg;   - powder for inhalation - 62.5 mcg - active: umeclidinium bromide 74.2ug equivalent to umeclidinium 62.5 mcg   excipient: lactose monohydrate magnesium stearate - incruse ellipta is indicated as a long-term once daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Anoro Ellipta 62.5mcg/ 25mcg (equivalent to 55/ 22mcg delivered dose) Dry Powder for Inhalation Philippines - English - FDA (Food And Drug Administration)

anoro ellipta 62.5mcg/ 25mcg (equivalent to 55/ 22mcg delivered dose) dry powder for inhalation

glaxosmithkline philippines inc. - umeclidinium bromide , vilanterol (as trifenatate) - dry powder for inhalation - 62.5mcg/ 25mcg (equivalent to 55/ 22mcg delivered dose)